Advertisement

Pfizer requests U.S. emergency use for its COVID-19 vaccine in kids aged 12-15

Click to play video: 'Pfizer says its COVID-19 vaccine effective for kids aged 12-15' Pfizer says its COVID-19 vaccine effective for kids aged 12-15
WATCH: Pfizer says its COVID-19 vaccine effective for kids aged 12-15 – Mar 31, 2021

Pfizer and its German partner BioNTech said on Friday they have requested the U.S. Food and Drug Administration to expand the emergency use of their COVID-19 vaccine in adolescents aged 12 to 15.

In March, the drugmakers said the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year olds in a clinical trial.

Read more: Pfizer says COVID-19 vaccine is 100% effective in protecting kids aged 12-15 in trial

Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer. Inoculating children and young people is considered a critical step toward reaching “herd immunity” and taming the pandemic, according to experts.

The companies plan to request similar rulings by other regulatory authorities globally in the coming days.

Story continues below advertisement

The Pfizer/BioNTech two-shot vaccine is already authorized for use in people as young as 16.

Sponsored content